Cargando…

Long-acting insulin analogues for type 1 diabetes: An overview of systematic reviews and meta-analysis of randomized controlled trials

BACKGROUND: The comparison between long acting insulin analogues (LAIA) and human insulin (NPH) has been investigated for decades, with many randomized controlled trials (RCTs) and systematic reviews giving mixed results. This overlapping and contradictory evidence has increased uncertainty on cover...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laranjeira, Fernanda O., de Andrade, Keitty R. C., Figueiredo, Ana C. M. G., Silva, Everton N., Pereira, Mauricio G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896894/ https://www.ncbi.nlm.nih.gov/pubmed/29649221 http://dx.doi.org/10.1371/journal.pone.0194801

Ejemplares similares

Budget Impact of Long-Acting Insulin Analogues: The Case in Brazil
por: Laranjeira, Fernanda O, et al.
Publicado: (2016)

Axillary surgical approach in metastatic breast cancer patients: a systematic review and meta-analysis
por: Lisboa1a, Fabiana C A P, et al.
Publicado: (2020)

Prevalence of Frailty in Latin America and the Caribbean: A Systematic Review and Meta-Analysis
por: Da Mata, Fabiana Araújo Figueiredo, et al.
Publicado: (2016)

Sleep quality assessment in chronic rhinosinusitis patients submitted to endoscopic sinus surgery: a meta-analysis()
por: Guttemberg, Manuela Dowsley A., et al.
Publicado: (2019)

Molecular Characterisation of Long-Acting Insulin Analogues in Comparison with Human Insulin, IGF-1 and Insulin X10
por: Hansen, Bo F., et al.
Publicado: (2012)

Knowledge translation in the reality of Brazilian public health
por: de Andrade, Keitty Regina Cordeiro, et al.
Publicado: (2020)

Effect of the long-acting insulin analogues glargine and degludec on cardiomyocyte cell signalling and function
por: Hartmann, Thorsten, et al.
Publicado: (2016)

Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications
por: Godman, Brian, et al.
Publicado: (2021)

Subcutaneous fast-acting insulin analogues, alone or in combination with long-acting insulin, versus intravenous regular insulin infusion in patients with diabetic ketoacidosis: protocol for an updated systematic review and meta-analysis of randomised trials
por: Lim, Beng Leong, et al.
Publicado: (2023)

A nationwide cohort study for comparative vascular safety of long-acting insulin analogue versus intermediate-acting human insulin in type 2 diabetes
por: Yang, Chun-Ting, et al.
Publicado: (2021)

Prescription patterns of long-acting somatostatin analogues
por: Machado-Alba, Jorge Enrique, et al.
Publicado: (2017)

Corrigendum to “Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications”
por: Godman, Brian, et al.
Publicado: (2023)

Functional disability of adults in Brazil: prevalence and associated factors
por: de Andrade, Keitty Regina Cordeiro, et al.
Publicado: (2015)

Rapid-Acting Insulin Analogues Versus Regular Human Insulin: A Meta-Analysis of Effects on Glycemic Control in Patients with Diabetes
por: Nicolucci, Antonio, et al.
Publicado: (2019)

Potential Role of Ultrafast-acting Insulin Analogues in the Treatment of Diabetic Ketoacidosis
por: Koufakis, Theocharis, et al.
Publicado: (2022)

Short-acting insulin analogues versus regular human insulin on postprandial glucose and hypoglycemia in type 1 diabetes mellitus: a systematic review and meta-analysis
por: Melo, Karla F. S., et al.
Publicado: (2019)

Efficacy, Pharmacokinetics, Biodistribution and Excretion of a Novel Acylated Long-Acting Insulin Analogue INS061 in Rats
por: Pan, Kai, et al.
Publicado: (2021)

Degludec: the new ultra-long insulin analogue
por: Tambascia, Marcos Antonio, et al.
Publicado: (2015)

Corrigendum: Usefulness and Potential Pitfalls of Long-Acting Growth Hormone Analogues
por: Yuen, Kevin C. J., et al.
Publicado: (2021)

Long-acting muscarinic antagonists vs. long-acting β (2) agonists in COPD exacerbations: a systematic review and meta-analysis
por: Maia, Israel Silva, et al.
Publicado: (2017)

The Effect of Long Acting Somatostatin Analogue SMS 201-995 in Acromegaly
por: Choi, Chul Joon, et al.
Publicado: (1987)

Association of Cardiovascular Outcomes and Mortality With Sustained Long-Acting Insulin Only vs Long-Acting Plus Short-Acting Insulin Treatment
por: Schroeder, Emily B., et al.
Publicado: (2021)

Glycemic Effects of Once-a-Day Rapid-Acting Insulin Analogue Addition on a Basal Insulin Analogue in Korean Subjects with Poorly Controlled Type 2 Diabetes Mellitus
por: Choe, Eun Yeong, et al.
Publicado: (2012)

Treatment of advanced pancreatic cancer with the long-acting somatostatin analogue lanreotide: in vitro and in vivo results
por: Raderer, M, et al.
Publicado: (1999)

Prevalence of hypertension among adolescents: systematic review and meta-analysis
por: Gonçalves, Vivian Siqueira Santos, et al.
Publicado: (2016)

Analogue to Digital and Digital to Analogue (AD/DA) Conversion Techniques: An Overview
por: John Pett (SL-PO)
Publicado: (2002)

Long-Acting Somatostatin Analogue Safety Monitoring Protocol for Outpatients With Neuroendocrine Tumors
por: Gabrielsen, Jordan, et al.
Publicado: (2019)

Botulinum Toxin in Facial Aesthetics Affects the Emotion Process: A Meta-analysis of Randomized Controlled Trials
por: Costa, Ana Carolina de Figueiredo, et al.
Publicado: (2022)

Current european regulatory perspectives on insulin analogues
por: Enzmann, Harald G, et al.
Publicado: (2011)

Assignment of polymorphic species of insulin analogues in ion mobility mass spectroscopy
por: Fávero-Retto, Maely P., et al.
Publicado: (2016)

Replacement of neutral protamine Hagedorn insulin with the long‐acting insulin analogue, detemir, improves glycemic control without weight gain in basal–bolus insulin therapy in Japanese patients with type 1 diabetes
por: Hayakawa, Taro, et al.
Publicado: (2011)

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
por: Hemkens, L. G., et al.
Publicado: (2009)

Type 1 Ig-E mediated allergy to human insulin, insulin analogues and beta-lactam antibiotics()
por: Andrade, Pedro, et al.
Publicado: (2012)

Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
por: Correll, Christoph U., et al.
Publicado: (2021)

The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future
por: Godman, Brian, et al.
Publicado: (2021)

A novel long-acting glucose-dependent insulinotropic peptide analogue: enhanced efficacy in normal and diabetic rodents
por: Tatarkiewicz, K, et al.
Publicado: (2014)

Effects of Ultra-Long-Acting Insulin Compared to Long-Acting Insulin on Diabetic Ketoacidosis Incidence in Type 1 Diabetes Mellitus Patients
por: Alsofiani, Wafa A, et al.
Publicado: (2022)

Glucagon-like peptide-1 analogues: An overview
por: Gupta, Vishal
Publicado: (2013)

Engineering of Insulin Receptor Isoform-Selective Insulin Analogues
por: Glendorf, Tine, et al.
Publicado: (2011)

Long-acting insulin allergy in a diabetic child
por: Mastrorilli, Carla, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9m1p31aa0ec0opso6vpttecftu